Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Endocrinology|February 1, 1980
Relationships between thyroid hormone and glucocorticoid effects in GH3 pituitary cellsM H Perrone, T L Greer, P M HinkleJournal of Cardiovascular Pharmacology|January 1, 1997
Regional hemodynamic dose-response of lemakalim and glybenclamide in anesthetized ratsG J Smits, M H Perrone, B F CoxCirculation Research|February 1, 1981
Acute hypertension after the local injection of kainic acid into the nucleus tractus solitarii of ratsW T Talman, M H Perrone, D J ReisThe Journal of Pharmacology and Experimental Therapeutics|March 1, 1985
Pharmacological analysis of alpha-2 adrenergic mechanisms in nociception and ataxiaD Luttinger, R Ferrari, M H Perrone, et al.Arzneimittel-Forschung|August 1, 1996
1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthaseD Amin, S A Cornell, M H Perrone, et al.Hypertension (Dallas, Tex. : 1979)|August 1, 1993
Angiotensin subtype 1 blockade selectively potentiates adenosine subtype 2-mediated vasodilationG J Smits, J M Kitzen, M H Perrone, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1990
Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitroM H Perrone, L T Hamel, R A Ferrari, et al.Circulation Research|September 1, 1990
Differential alteration of vascular reactivity in rabbit aorta with modest elevation of serum cholesterolL A Merkel, L M Rivera, G E Bilder, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Protein kinase C and vascular smooth muscle contractility: effects of inhibitors and down-regulationL A Merkel, L M Rivera, D J Colussi, et al.European Journal of Pharmacology|May 27, 1992
In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitorL A Merkel, L M Rivera, M H Perrone, et al.Pageof 6